These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3080855)

  • 1. Valproate and myoclonus.
    Chapman AG
    Adv Neurol; 1986; 43():661-74. PubMed ID: 3080855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlormethiazole--mode of action.
    Ogren SO
    Acta Psychiatr Scand Suppl; 1986; 329():13-27. PubMed ID: 2875615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT.
    Jenner P; Pratt JA; Marsden CD
    Adv Neurol; 1986; 43():629-43. PubMed ID: 2418652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pharmacological manipulation of inhibitory and excitatory neurotransmitter systems on seizure behavior in the Mongolian gerbil.
    Löscher W
    J Pharmacol Exp Ther; 1985 Apr; 233(1):204-13. PubMed ID: 2858579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antimyoclonic action of clonazepam through a GABA--independent mechanism.
    Paul V; Krishnamoorthy MS
    Indian J Physiol Pharmacol; 1989; 33(4):243-6. PubMed ID: 2620967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanisms of action of valproic acid in myoclonus.
    Van Woert MH; Chung EY
    Adv Neurol; 1986; 43():653-60. PubMed ID: 2418654
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in and modulation of receptor activity in hepatic encephalopathy].
    Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K
    Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p,p'-DDT-induced myoclonus in the rat and its application as an animal model of 5-HT-sensitive action myoclonus.
    Pratt JA; Rothwell J; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():577-88. PubMed ID: 2418651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats.
    Paul V; Krishnamoorthy MS
    Indian J Physiol Pharmacol; 1990 Apr; 34(2):139-42. PubMed ID: 2147669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
    White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sodium valproate--current status of pharmacological research].
    Chapman AG
    Praxis (Bern 1994); 1994 Oct; 83(40):1106-10. PubMed ID: 7524125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture.
    McLean MJ; Macdonald RL
    J Pharmacol Exp Ther; 1986 Jun; 237(3):1001-11. PubMed ID: 3086538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between GABAergic and serotoninergic systems with excitatory amino acid neurotransmission in the hypothalamic control of gonadotropin secretion in prepubertal female rats.
    Scacchi P; Carbone S; Szwarcfarb B; Rondina D; Wuttke W; Moguilevsky JA
    Brain Res Dev Brain Res; 1998 Jan; 105(1):51-8. PubMed ID: 9497079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of antiepileptic and antimyoclonic drugs.
    Pranzatelli MR; Nadi NS
    Adv Neurol; 1995; 67():329-60. PubMed ID: 8848979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs acting on amino acid neurotransmitters.
    Meldrum BS
    Adv Neurol; 1986; 43():687-706. PubMed ID: 2868623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity.
    Baldino F; Geller HM
    J Pharmacol Exp Ther; 1981 May; 217(2):445-50. PubMed ID: 6785416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats.
    Rohlfs A; Rundfeldt C; Koch R; Löscher W
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1305-14. PubMed ID: 8667191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDT-induced myoclonus: serotonin and alpha noradrenergic interaction.
    Hwang EC; Van Woert MH
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):257-66. PubMed ID: 37558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeking a mechanism of action for the novel anticonvulsant lacosamide.
    Errington AC; Coyne L; Stöhr T; Selve N; Lees G
    Neuropharmacology; 2006 Jun; 50(8):1016-29. PubMed ID: 16620882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain.
    Bolaños JP; Medina JM
    Mol Pharmacol; 1993 Mar; 43(3):487-90. PubMed ID: 8450838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.